Napalm You are correct that SYME could release results in June but that.would only be possible if they argue COVID related delays which I think is unlikely to occur. 4 months is standard deadline
Good to see that U.K. regulatory approval confirmed as deal adds significant scale to U.K. business and potential synergy cost savings and capital efficiencies plus greater cash generation.
RE: This is getting pretty exciting. Something brewing.5 Apr 2022 22:09
Castle SYME could get an accounts extension of 2 months if they cited COVID delays but I am sure that Amy Benning will get accounts out by the promised time. Based on interims and disclosures made she knows her stuff in my opinion.
Why are you suggesting that SYME is performing IM but not issuing an RNS about entering into such a white label agreement with Lloyds Bank. Sounds a bit like market abuse to me.
I think my risk of libel because I stated that I think your assumption is bs and not supported by a company RNS are limited.
For two years after supposed proofs of concept pre IPO for which suspiciously no details are provided SYME has failed to raise a penny in IM finance.
Bulls cite COVID and new asset class but even they must be worrying is there a more fundamental problem?
I wonder how Stormharbour and Apex fund launches are proceeding? Must be ready to fly soon?
Finally if it’s such a great idea why hasn’t a rival business in an adjacent business space like Taulia sought to replicate the business? The bulls will cite years of SYME development but the reality is that securitisation structures are offered by all major banks and on the front end inventory systems Taulia have numerous active customers so joining the two together would be relatively straightforward. Also Taulia is now owned by SAP has deep pockets and massive credibility in software space.
SYME’s inventory monetisation companies never take physical possession of the inventory nor do they intend to and the SYME blurb states that SYME customers can continue to sell the inventory to original customers.
Under the above two paragraphs of IFRS 15 this means no sale has occurred.
The bulls will cite SYME says it works but SYME have never published their advice or explained how it works.
I do wonder if this is why SYME can never raise finance because backers when they realise this don’t want to finance a scheme which doesn’t work.
No doubt some will say this was all checked by the FCA but the FCA approved the Prospective with the £224 million accounting error which in my view casts doubt over their accounting abilities.
Anyway looks like monster RNS is delayed until another day.
RE: Tradeflow business value will have grown since Acquisituon1 Apr 2022 12:40
SYME actually paid £7 million upfront for Tradeflow in cash and shares. It has to pay additional deferred consideration depending on revenue targets.
If your right and it has to pay another £24 million in cash or shares for deferred consideration to meet the £31 million valuation of Tradeflow you cite.
SYME doesn’t have the cash and £24 million in shares would be rather dilutive unless share price increases dramatically.
Stock trades at discount to nav. It can take time for market to respond to such issues for a small cap with a low float but I brought some more today because I can be a patient holder of an undervalued stock.
Clearly some challenges in Sweden with customers transferring to cheaper rival which may have improved in 2022 and old L&G business in Holland has issues which is why It was sold.
2022 interims will hopefully reflect benefit of two acquisitions one of which is huge for U.K. business.
2022 will see increase in scale and profitability once two acquisitions complete